| scholarly article | Q13442814 |
| P356 | DOI | 10.4049/JIMMUNOL.178.11.6876 |
| P698 | PubMed publication ID | 17513736 |
| P50 | author | Ian R Rifkin | Q55381294 |
| P2093 | author name string | Shizuo Akira | |
| Ann Marshak-Rothstein | |||
| Christophe Richez | |||
| Kei Yasuda | |||
| Neerja Agrawal | |||
| Joseph W Maciaszek | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 6876-6885 | |
| P577 | publication date | 2007-06-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production | |
| P478 | volume | 178 |
| Q38537618 | A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus |
| Q40342539 | A distinct subset of plasmacytoid dendritic cells induces activation and differentiation of B and T lymphocytes |
| Q35347846 | A temporal gate for viral enhancers to co-opt Toll-like-receptor transcriptional activation pathways upon acute infection |
| Q37607510 | Activating systemic autoimmunity: B's, T's, and tolls. |
| Q36407966 | Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands |
| Q46821191 | Ageing is associated with diminished apoptotic cell clearance in vivo |
| Q33924642 | Altered B cell signalling in autoimmunity |
| Q90341652 | BAFF inhibition in SLE-Is tolerance restored? |
| Q26748941 | Breakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic Cells |
| Q36302345 | Characterising the immune profile of the kidney biopsy at lupus nephritis flare differentiates early treatment responders from non-responders |
| Q33933077 | Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus |
| Q35173733 | Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus |
| Q37270799 | DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo |
| Q57294852 | Differential and Overlapping Immune Programs Regulated by IRF3 and IRF5 in Plasmacytoid Dendritic Cells |
| Q26773124 | Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus Erythematosus |
| Q41937471 | Double-stranded DNA activates glomerular endothelial cells and enhances albumin permeability via a toll-like receptor-independent cytosolic DNA recognition pathway. |
| Q35833264 | Effects of IRF5 lupus risk haplotype on pathways predicted to influence B cell functions |
| Q36637528 | Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus |
| Q39669563 | Exon 6 variants carried on systemic lupus erythematosus (SLE) risk haplotypes modulate IRF5 function. |
| Q37625812 | Expression of an anti-RNA autoantibody in a mouse model of SLE increases neutrophil and monocyte numbers as well as IFN-I expression |
| Q38531462 | Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response |
| Q43077954 | Fundamental roles of the innate-like repertoire of natural antibodies in immune homeostasis |
| Q34187236 | Gender-dependent Expression of Murine Irf5 Gene: Implications for Sex Bias in Autoimmunity |
| Q34287053 | Gene expression during the generation and activation of mouse neutrophils: implication of novel functional and regulatory pathways |
| Q38972234 | Genetic association and interaction between the IRF5 and TYK2 genes and systemic lupus erythematosus in the Han Chinese population |
| Q35542816 | Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus |
| Q37741802 | Genetics of SLE: evidence from mouse models |
| Q36438876 | Genetics of SLE: functional relevance for monocytes/macrophages in disease |
| Q35921093 | Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis |
| Q90225438 | Heightened TLR7/9-Induced IL-10 and CXCL13 Production with Dysregulated NF-ҝB Activation in CD11chiCD11b+ Dendritic Cells in NZB/W F1 Mice |
| Q33804141 | IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus |
| Q38040748 | IL-17: a new actor in IFN-driven systemic autoimmune diseases |
| Q39160951 | IRF-5 and NF-κB p50 co-regulate IFN-β and IL-6 expression in TLR9-stimulated human plasmacytoid dendritic cells. |
| Q35142708 | IRF4 deficiency abrogates lupus nephritis despite enhancing systemic cytokine production |
| Q35070231 | IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosis |
| Q36494607 | IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice |
| Q27489661 | Induction of IFN-β and the Innate Antiviral Response in Myeloid Cells Occurs through an IPS-1-Dependent Signal That Does Not Require IRF-3 and IRF-7 |
| Q36238033 | Inhibition of JAKs in macrophages increases lipopolysaccharide-induced cytokine production by blocking IL-10-mediated feedback |
| Q35096709 | Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells. |
| Q40514474 | Innate and humoral recognition of the products of cell death: differential antigenicity and immunogenicity in lupus |
| Q27652424 | Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5 |
| Q37994060 | Integration of B cell responses through Toll-like receptors and antigen receptors |
| Q38123907 | Interferon regulatory factor 5 and autoimmune lupus. |
| Q34261880 | Interferon regulatory factor 5-dependent immune responses in the draining lymph node protect against West Nile virus infection |
| Q33975488 | Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2. |
| Q35587718 | Involvement of DNA-PKcs in the type I IFN response to CpG-ODNs in conventional dendritic cells in TLR9-dependent or -independent manners |
| Q36935572 | Irf5-deficient mice are protected from pristane-induced lupus via increased Th2 cytokines and altered IgG class switching |
| Q24312041 | Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling |
| Q40112081 | Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus |
| Q84199414 | Microparticles as autoadjuvants in the pathogenesis of SLE |
| Q34090517 | Murine B cell response to TLR7 ligands depends on an IFN-beta feedback loop |
| Q38772739 | Myeloid Populations in Systemic Autoimmune Diseases. |
| Q37270902 | Myeloid dendritic cells correlate with clinical response whereas plasmacytoid dendritic cells impact autoantibody development in rheumatoid arthritis patients treated with infliximab |
| Q86870797 | No evidence for a genetic association of IRF4 with systemic lupus erythematosus in a Chinese population |
| Q28081728 | Nucleic Acid-Sensing Receptors: Rheostats of Autoimmunity and Autoinflammation |
| Q40173384 | Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation |
| Q30498311 | Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-beta |
| Q36780004 | Phenotype and function of B cells and dendritic cells from interferon regulatory factor 5-deficient mice with and without a mutation in DOCK2. |
| Q27485637 | Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history |
| Q37769441 | Plasmacytoid dendritic cells in antiviral immunity and autoimmunity |
| Q37222231 | Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. |
| Q33380975 | Prevention of murine antiphospholipid syndrome by BAFF blockade |
| Q36322611 | Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model |
| Q38090919 | Protective autoantibodies in the rheumatic diseases: lessons for therapy |
| Q34708883 | Protein kinase IKKβ-catalyzed phosphorylation of IRF5 at Ser462 induces its dimerization and nuclear translocation in myeloid cells. |
| Q90628013 | RAG gene defects at the verge of immunodeficiency and immune dysregulation |
| Q34563170 | RNA-Seq for enrichment and analysis of IRF5 transcript expression in SLE. |
| Q33964547 | Recent advances in the genetics of systemic lupus erythematosus |
| Q24293755 | Regulation of immunity and oncogenesis by the IRF transcription factor family |
| Q33815085 | Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes |
| Q35161570 | Retracted: Genetic Polymorphism of Interferon Regulatory Factor 5 (IRF5) Correlates with Allograft Acute Rejection of Liver Transplantation |
| Q37801738 | Role for toll-like receptors in autoimmune disease: The example of systemic lupus erythematosus |
| Q30415532 | Salivary gland hypofunction induced by activation of innate immunity is dependent on type I interferon signaling |
| Q92711767 | Scopoletin Suppresses Activation of Dendritic Cells and Pathogenesis of Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling |
| Q36907736 | Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity |
| Q35889350 | Spontaneous mutation of the Dock2 gene in Irf5-/- mice complicates interpretation of type I interferon production and antibody responses |
| Q42574145 | Striking Immune Phenotypes in Gene-Targeted Mice Are Driven by a Copy-Number Variant Originating from a Commercially Available C57BL/6 Strain |
| Q33723523 | Subcutaneous allergen immunotherapy restores human dendritic cell innate immune function |
| Q33765598 | T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus? |
| Q43097078 | TLR sensing of bacterial spore-associated RNA triggers host immune responses with detrimental effects. |
| Q33807599 | TLR4 ligands induce IFN-alpha production by mouse conventional dendritic cells and human monocytes after IFN-beta priming |
| Q37019634 | TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus |
| Q28292240 | TLR8 deficiency leads to autoimmunity in mice |
| Q33902262 | TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus |
| Q37795596 | Targeting Toll-like receptors for treatment of SLE |
| Q37150404 | The role of type 1 interferon in systemic sclerosis |
| Q59791524 | Therapeutic Targeting of IRFs: Pathway-Dependence or Structure-Based? |
| Q37838577 | Toll-like receptor driven B cell activation in the induction of systemic autoimmunity |
| Q34114826 | Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice |
| Q48246342 | Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Activates Type I Interferon Signals in Lupus Nephritis |
| Q37350900 | Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus. |
| Q30413385 | Type I interferon receptor deficiency prevents murine Sjogren's syndrome |
| Q36773380 | Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response |
| Q37330569 | Viral RNA and DNA trigger common antiviral responses in mesangial cells. |
| Q37413676 | Viral RNA induces type I interferon-dependent cytokine release and cell death in mesangial cells via melanoma-differentiation-associated gene-5: Implications for viral infection-associated glomerulonephritis |
Search more.